Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
8.14
+0.15 (1.88%)
Jul 16, 2025, 2:45 PM CST
SHA:600867 Revenue
Tonghua Dongbao Pharmaceutical had revenue of 651.50M CNY in the quarter ending March 31, 2025, with 10.17% growth. This brings the company's revenue in the last twelve months to 2.07B, down -31.05% year-over-year. In the year 2024, Tonghua Dongbao Pharmaceutical had annual revenue of 2.01B, down -34.66%.
Revenue (ttm)
2.07B
Revenue Growth
-31.05%
P/S Ratio
7.50
Revenue / Employee
606.93K
Employees
3,410
Market Cap
15.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.01B | -1.07B | -34.66% |
Dec 31, 2023 | 3.08B | 296.96M | 10.69% |
Dec 31, 2022 | 2.78B | -489.44M | -14.98% |
Dec 31, 2021 | 3.27B | 375.73M | 12.99% |
Dec 31, 2020 | 2.89B | 115.02M | 4.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |